Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.3 USD | -0.94% | -1.23% | -3.45% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.45% | 186B | |
-2.67% | 107B | |
-3.88% | 67.44B | |
+3.18% | 50.03B | |
+16.08% | 47.81B | |
+4.79% | 41.03B | |
+1.57% | 26.85B | |
+2.79% | 25.82B | |
-0.33% | 25.01B | |
+16.55% | 24.74B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Earnings Flash (ABT) ABBOTT Posts Q1 Revenue $9.96B, vs. Street Est of $9.87B